Continuous glucose monitors for non-diabetics: are they worth it?
CGM for non-diabetics went mainstream after the FDA cleared the first over-the-counter monitor in 2024. What normal glucose looks like, and when a CGM helps.
A Cinder series
Longevity & Diagnostics
Biological age tests, ApoB, CGMs, full-body MRI, executive physicals and longevity drugs: which tests and interventions are worth it, and which are expensive anxiety.
ApoB and Lp(a): the heart tests your annual physical may miss
ApoB and Lp(a) tests can reveal heart risk a standard cholesterol panel misses. What each measures, what the research shows, and how founders can ask for them.
Biological age tests: what epigenetic clocks can and can't tell you
Biological age tests use epigenetic clocks to read DNA methylation. What the research supports, where the numbers wobble, and how founders should use a result.